Sung Ji Kim

Title: Innovations by Sung Ji Kim in Drug-Food Interaction Prediction

Introduction

Sung Ji Kim is an accomplished inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmacology, particularly in understanding the interactions between drugs and food. Her innovative approach has the potential to enhance drug efficacy and patient safety.

Latest Patents

Sung Ji Kim holds a patent for a "Method of predicting drug-food interaction." This invention provides a method for predicting food-drug interactions in vivo, specifically for orally administered drugs that interact with digestive enzymes in the gastrointestinal tract. The method involves measuring the activity of the drug against digestive enzymes in vitro. This is based on the observation that food ingestion can decrease drug absorption due to interactions with digestive enzymes. Furthermore, the invention outlines methods to minimize changes in drug absorption caused by food intake, such as the introduction of prodrugs, modification of the drug's chemical structure, and the design of drug formulations.

Career Highlights

Sung Ji Kim has established herself as a key figure in her field through her innovative research and development efforts. Her work at LG Life Sciences, Limited has positioned her at the forefront of pharmaceutical advancements. She is dedicated to improving drug delivery systems and enhancing therapeutic outcomes for patients.

Collaborations

Sung Ji Kim collaborates with talented colleagues, including Aeri Kim and Kwan Hyung Cho. These partnerships foster a dynamic research environment that encourages innovation and the sharing of ideas.

Conclusion

Sung Ji Kim's contributions to the understanding of drug-food interactions represent a significant advancement in pharmacology. Her innovative methods have the potential to improve drug efficacy and patient safety, making her a notable inventor in the field.